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Ganglioneuromas are considered to be part of the neuroblastoma series of tumors, 
which evolve from the sympathogonia of neural crest origin. As imaging techniques 
have become more widely practiced, the number of ganglioneuromas detected inci-
dentally has increased. Preoperative diagnosis of retroperitoneal ganglioneuromas is 
often difficult and the diagnosis is usually based on histopathological findings after 
surgical excision of the tumor. We present two cases of this unique disease entity and 
discuss its clinical presentation, therapeutic approach, and clinical outcome.
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1. Introduction
Ganglioneuromas are fully differentiated and typi-
cally nonmetabolically active tumors of the sym-
pathetic nervous system. They are considered to 
be part of the neuroblastoma series of tumors that 
includes neuroblastomas and ganglioneuroblasto-
mas, which evolve from the sympathogonia of neu-
ral crest origin.1 These tumors occur in all age 
groups but are more common in children above the 
age of 10 years.2 Most ganglioneuromas are asymp-
tomatic and are found incidentally and with simi-
lar frequencies in both sexes. Ganglioneuromas are 
relatively difficult to distinguish from other tumors 
because of the lack of specific imaging findings.3 
As imaging techniques such as computed tomogra-
phy (CT) and ultrasonography have become more 
widely practiced, the number of ganglioneuromas 
detected incidentally has increased. However, it is 
difficult to make an accurate preoperative diagno-
sis of ganglioneuroma.4 Early detection is impor-
tant, however, because complete resection results 
in a cure and the tumor rarely undergoes malignant 
transformation.5
Most studies of retroperitoneal ganglioneuromas 
have been limited to case reports or case series 
consisting of small numbers of cases. This study 
describes a further two cases of this relatively un-
common disease entity.
2. Patients and Methods
A retrospective review of the hospital and pathology 
records of the Department of Urology, University 
of Erlangen Medical Center, was conducted with 
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institutional board approval from January 2000 to 
January 2008. Admission and discharge records were 
reviewed and examined for patients diagnosed with 
ganglioneuromas. Two patients were identified and 
their complete clinical and pathologic data were 
obtained.
3. Case Reports
3.1. Case 1
A 5-year-old female patient presented to our de-
partment in 2005 with a suspect renal mass discov-
ered accidentally by ultrasonography by her family 
doctor. Ultrasound revealed a homogeneous mass 
with well-defined borders, detected at the left api-
cal pole. Magnetic resonance imaging (MRI) revealed 
a paravertebral mass measuring 5.2 cm ˜  4.1 cm, 
anterior to the left kidney and infiltrating the neu-
ral foramen on the left side (Figure 1). This mass 
partly displaced the psoas muscle at the level of 
T12/L1 and was poorly defined on the images. 
There was no suggestion of lymph node involve-
ment. A preoperative diagnosis of retroperitoneal 
neuroblastoma was made and surgical resection was 
performed.
A midline laparotomy was made for laterocolic 
extirpation of the mass, sparing the residual left 
kidney. The lateral portion was mobilized and re-
moved, with renal vessel preservation. The exten-
sion of the mass into the psoas muscle, the spinal 
canal at the level of L1 and the ganglionic area 
made complete resection impossible. Frozen sec-
tions showed the mass to be grossly and histologi-
cally compatible with ganglioneuroma (Figures 2 
and 3). In order to avoid injury of the spinal canal, 
the decision was made to perform a secondary op-
eration. Postoperative histologic examination re-
vealed a mixture of immature and mature ganglion 
fibers and neuronal cells that were outside the renal 
capsule, suggestive of retroperitoneal ganglioneu-
roma with sparing of the renal parenchyma.
After interdisciplinary consultations with pedi-
atric surgeons and neurosurgeons, and due to the 
possibility of paraplegia caused by progressive tu-
mor growth, the patient was scheduled for radical 
Figure 1 Abdominal magnetic resonance imaging of a 
5-year-old female patient revealing a paravertebral 
mass measuring 5.2 cm ˜  4.1 cm, anterior to the left kid-
ney and infiltrating the neural foramen on the left side, 
thought to be a retroperitoneal ganglioneuroma.
Figure 3 Histological appearance of a spindle cell 
tumor with fascicles composed of neuritic processes, 
Schwann cells, perineural cells and ganglion cells com-
patible with that of a primary ganglioneuroma.
Figure 2 Gross appearance of a 5.2-cm ˜  4.1 cm encap-
sulated mass of firm consistency with a homogenous, 
solid, grayish-white cut surface, histologically confirmed 
to be a retroperitoneal ganglioneuroma.
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removal of the residual mass. The patient was free 
of disease 6 months after surgery employing a left 
paravertebral dorsolumbar approach. No evidence 
of tumor recurrence had been detected at the time 
of writing, after close follow-up.
3.2. Case 2
An 8-year-old male patient presented to our de-
partment in 2006 with a suspect renal mass discov-
ered accidentally by ultrasonography by his family 
doctor. Ultrasound revealed a homogeneous mass 
with well-defined borders, between the upper pole 
of the right kidney and the liver margin. CT revealed 
a 5.6 cm ˜  3.7 cm intrahepatorenal tumor. The tumor 
was homogeneous with relatively low attenuation, 
less than that of muscle and slightly enhanced by 
contrast medium. No involvement of the renal vein 
or inferior vena cava was present and the lymph 
nodes were not enlarged. A preoperative diagnosis 
of retroperitoneal ganglioneuroma was made and 
surgical resection was performed. Using an inter-
costal incision, the right kidney was exposed and the 
intrahepatorenal mass was identified. The tumor was 
mobilized and completely removed. The postoper-
ative histopathologic examination showed Schwann 
cells admixed with mature ganglion cells. The 
tumor was diagnosed as a retroperitoneal ganglio-
neuroma with sparing of the liver and renal paren-
chyma. The postoperative course was uneventful, 
and there was no recurrence at the time of writing, 
after close follow-up.
4. Discussion
Ganglioneuromas are typically slow growing, benign 
tumors with a tendency to remain clinically silent 
for a considerable period. Preoperative diagnosis of 
retroperitoneal ganglioneuromas is often difficult, 
and the diagnosis is usually based on histopatho-
logic findings after surgical excision of the tumor. 
To date, there have been only four case reports 
describing cytologic diagnosis of ganglioneuromas 
by fine-needle aspiration biopsy cytology.6 Although 
fine-needle aspiration cytology has been reported 
to be useful in the preoperative diagnosis of adre-
nal ganglioneuroma in some cases, the tumoral tis-
sue can contain fractions of less well-differentiated 
areas, and surgical exploration is therefore re-
quired to achieve a definitive diagnosis and risk 
assessment.
Ganglioneuromas can occur spontaneously, as a 
result of the necrosis of immature neuroblasts from 
malignant neuroblastomas at primary or metastatic 
sites, or during either chemotherapy or radiation 
therapy for neuroblastomas.1
Symptomatic ganglioneuromas are rare, and 
symptoms mostly result from compression of the 
surrounding structures by the mass. Abdominal tu-
mors may lead to abdominal pain, vomiting, consti-
pation, weight loss, and walking pain.3 Additionally, 
symptoms of autonomic dysfunction have been en-
countered in patients with hormone-secreting gan-
glioneuromas. Such symptoms have also been noted 
in patients with paravertebral ganglioneuromas that 
compressed the autonomic fibers of the lumbosac-
ral plexus.7 Furthermore, functional ganglioneuro-
mas that were found to release peptides such as 
vasoactive intestinal peptide, somatostatins and 
neuropeptide Y have been documented in the lit-
erature.8 Ganglioneuromas are most often located 
in the posterior mediastinum, followed by the ret-
roperitoneum and cervical region.9 Other sites of 
occurrence include the gastrointestinal tract, par-
apharyngeal area, bone, and supraclavicular area. 
Rarely, ganglioneuromas are encountered in the 
heart or even the spermatic cord1. Diffuse ganglio-
neuromatosis affecting any part of the gastrointes-
tinal tract has also been described,10 and may be 
associated with neurofibromatosis or the syndrome 
of multiple endocrine neoplasia type IIb.11 A rare 
case of a solitary cutaneous ganglioneuroma has 
also been reported.12
The differential diagnosis of ganglioneuroma 
includes neuroblastoma, ganglioneuroblastoma, neu-
rofibroma, schwannoma, adrenal adenoma, adren-
ocortical carcinoma, and pheochromocytoma.5
Grossly, the tumors consist of large, encapsulated 
masses with a firm consistency and a homogenous, 
solid, grayish-white cut surface. Microscopically, gan-
glioneuromas can be divided into two subtypes: 
The mature subtype includes spindle cell tumors 
resembling neuroblastomas but with fascicles com-
posed of neuritic processes, Schwann cells, and peri-
neural cells and showing numerous ganglion cells; 
the maturing subtype has a similar stroma, but 
with ganglion cells in different stages of matura-
tion, from fully mature cells to neuroblasts.13
As imaging techniques such as CT and ultra-
sonography have become more widely practiced, 
the number of ganglioneuromas detected inciden-
tally has increased. Ultrasonography usually reveals 
a homogeneous, hypoechogenic mass with well-
defined borders, while CT usually reveals a well-
defined mass with an oval shape, which tends to 
surround major blood vessels. The tumor is usually 
homogeneous with relatively low attenuation, less 
than that of muscle and slightly enhanced by con-
trast medium.14
MRI using standard echo T1-weighted and T2-
weighted images, as well as in- and out-phase 
chemical shift imaging, shows ganglioneuromas as 
homogeneous masses with a signal intensity less 
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than that of liver on T1-weighted MRI, and as het-
erogeneous masses with a predominant signal in-
tensity greater than that of liver on T2-weighted 
MRI. It shows no absolute change in signal intensity 
on chemical shift imaging. Dynamic studies dem-
onstrate the same enhancement pattern as that 
seen using CT.14
The management of ganglioneuromas is mainly by 
surgical resection, which can be either radical or 
staged. Due to its close relations to large vessels, 
some potentially life-threatening complications can 
arise during surgical resection. Surgery should be per-
formed under the following circumstances: Possibility 
of progression and recurrence, recurrence of neu-
roblastoma from ganglioneuroma, symptoms re-
sulting from the tumor, encroachment on vertebral 
foramina, marked growth in size, and increased se-
cretion of catecholamine.1
Preoperative or postoperative chemotherapy and 
radiotherapy are of no value, and such modalities 
are not only unnecessary in these patients, but can 
also cause side effects and may be associated with 
secondary malignancies at the tumor site after ra-
diotherapy. Most patients experience prolonged 
survival, without any evidence of progression.7 How-
ever, the possibility of slow progression and late re-
currence of ganglioneuromas cannot been excluded. 
Furthermore, the probability of recurrence of neu-
roblastoma from the ganglioneuroma is unknown. 
Hayes et al1 reported that removal of an abdomi-
nal ganglioneuroma with the surrounding lymph 
nodes revealed another ganglioneuroma in one of 
the lymph nodes. Kulkarni et al15 noted late malig-
nant transformation of a dormant ganglioneuroma. 
Drago et al16 reported on the spontaneous devel-
opment of a malignant peripheral nerve sheath 
tumor in a benign ganglioneuroma in an 11-year-old 
girl. Long-term postoperative follow-up is therefore 
necessary to assess the malignant potential of these 
tumors.17 If any progression of the tumor is sus-
pected during follow-up, re-biopsy or laparotomy 
may be indicated.
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